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Abstract 
Salmonid alphavirus subtype 3 (SAV3) causes pancreas disease (PD) and adversely affects salmonid aquaculture 
in Europe. A better understanding of disease transmission is currently needed in order to manage PD outbreaks. 
Here, we demonstrate the relationship between viral dose and the outcome of SAV3 infection in Atlantic salmon 
post-smolts using a bath challenge model. Fish were challenged at 12 °C with 3 different SAV3 doses; 139, 27 and 7 
TCID50 L
−1 of seawater. A dose of as little as 7 TCID50 L
−1 of seawater was able to induce SAV3 infection in the chal-
lenged population with a substantial level of variation between replicate tanks and, therefore, likely represents a dose 
close to the minimum dose required to establish an infection in a population. These data also confirm the highly 
infectious nature of SAV through horizontal transmission. The outcome of SAV3 infection, evaluated by the preva-
lence of viraemic fish, SAV3-positive hearts, and the virus shedding rate, was positively correlated to the original SAV3 
dose. A maximal shedding rate of 2.4 × 104 TCID50 L−1 of seawater h−1 kg−1 was recorded 10 days post-exposure 
(dpe) from the highest dose group. The method reported here, for the quantification of infectious SAV3 in seawater, 
could be useful to monitor PD status or obtain data from SAV3 outbreaks at field locations. This information could be 
incorporated into pathogen dispersal models to improve risk assessment and to better understand how SAV3 spreads 
between farms during outbreaks. This information may also provide new insights into the control and mitigation of 
PD.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Salmonid alphavirus (SAV), also referred to as Salmon 
pancreas disease virus (SPDV), is the aetiological agent 
of Pancreas disease (PD). PD adversely affects the pro-
duction of salmonids in many countries in Europe and 
North America [1–5]. It is considered to be one of the 
most economically important diseases affecting salmo-
nid production in Norway [6]. PD outbreaks in Norway 
occur during the seawater phase of both Atlantic salmon, 
Salmo salar L., and rainbow trout, Oncorhynchus mykiss 
(Walbaum), production cycles [7]. SAV belongs to the 
family Togaviridae, genus Alphavirus. The SAV genome 
is approximately 12 kilobases, and consists of a positive-
sense single-stranded RNA encoding genes for struc-
tural (E1-E3 and capsid), 6K, and non-structural proteins 
(nsP1–nsP4) [8]. Six subtypes of SAV (designated SAV 
1–6) have been identified based on partial sequences of 
the E2 and nsP3 genes [9], although this classification is 
not completely in agreement with serology-based crite-
ria [10, 11]. Up until 2011, SAV3 had been the only sub-
type reported to cause PD in Norwegian aquaculture [7, 
12]. Then, in 2011, the first case of SAV subtype 2 (SAV2) 
was detected [13], apparently following its introduction 
to Norway in 2010 [14, 15]. SAV2 has been reported to 
cause a milder form of PD than SAV3 [15–17], although 
Open Access
*Correspondence:  sonal.patel@imr.no 
1 Institute of Marine Research, Nordnesgaten 50, 5005 Bergen, Norway
Full list of author information is available at the end of the article
Page 2 of 13Jarungsriapisit et al. Vet Res  (2016) 47:102 
serological reactivity between these two subtypes has 
been shown to be similar [10].
PD occurs mainly via horizontal transmission [14, 16, 
18, 19], whereas vertical transmission has not been con-
vincingly demonstrated [20, 21]. According to currently 
available scientific information, infected farmed sal-
monids are the main reservoir of SAV [14]. In Norway, 
restrictions on the movement of infected fish are in place 
in order to prevent the spread of PD. However, water-
borne transmission of SAV via water currents cannot be 
prevented by movement restrictions. Viral shedding of 
SAV3 into seawater has been demonstrated from experi-
mentally infected fish after intra-peritoneal injection [22] 
and bath immersion [23]. Mucus and faeces have also 
been suggested as routes of SAV shedding and transmis-
sion [16]. In addition, previous studies have shown that 
SAV1 can survive in non-sterile seawater for up to 14 days 
at 10  °C [24] and that only slight changes in SAV2 titre 
occur after incubation at 37 °C for 1 h [25]. These survival 
data, taken together with previous studies showing that 
there is a high risk of contracting PD from neighbouring 
farms during an active outbreak [18], strongly suggest 
that SAV transmission by water currents is possible and 
even likely. However, to date, there is a lack of quantitative 
information regarding viral shedding and the infectious 
dose required to induce infection in populations.
Experimental infection and monitoring of disease pro-
gression is one of the ways to obtain a deeper under-
standing of disease transmission [26, 27]. However, 
monitoring disease progression on the same individual is 
not always a practical approach for experimental animals 
where animal welfare must be considered. Hence, moni-
toring the stages of infection and pathogen transmission 
is often based on the results from different individuals. 
More knowledge regarding the relationship between viral 
dose and the outcome of the infection, viral shedding 
from fish, and survival of SAV in the environment is of 
utmost importance for the development of effective PD 
management strategies. This information can be incor-
porated into hydrodynamic modelling of SAV dispersal 
during outbreaks (including direction and distance) to 
assess the risk of PD spread, and may also contribute to 
the design and application of better control measures.
In the present study, the aim was to determine the rela-
tionship between the viral dose and the outcome of the 
SAV3 infection in Atlantic salmon post-smolts by using a 
previously established bath challenge model in seawater 
[23]. The bath challenge model allows the SAV infection 
to proceed by the natural route, it ensures the accuracy 
of the exposure time, and it allows for control of the viral 
dose. In this study, the effects of different doses on viral 
shedding, prevalence of infected fish, and viral load in the 
blood and in the heart were measured. These parameters 
were used to infer both the minimum infectious dose of 
virus that can induce infection in the population and the 
viral shedding rates. These are the key parameters that 
can be used in a viral dispersal model in order to improve 
the risk assessment of SAV transmission during PD 
outbreaks.
Materials and methods
Fish and rearing conditions
Atlantic salmon were supplied by SalmoBreed, Osterøy, 
Norway and transported in freshwater to the fish rearing 
facility at Industrial and Aquatic Laboratory (ILAB), Ber-
gen High Technology Centre, Bergen, Norway, for produc-
tion of post-smolts. The fish were screened by the supplier 
and tested negative for SAV, Infectious salmon anaemia 
virus (ISAV), Piscine orthoreovirus (PRV), Infectious pan-
creatic necrosis virus (IPNV) and Piscine myocarditis virus 
(PMCV). Experimental fish were unvaccinated Atlantic 
salmon post-smolts with an average weight of 50.6 ± 6.8 g 
and an average length of 16.3 ± 0.8 cm. Seawater (34‰) 
supplied throughout the experimental period was filtered 
through a 20 μm filter, UV-sterilized, and maintained at a 
constant temperature of 12 °C. The seawater flow rate and 
oxygen saturation were maintained at 300 L h−1 and >80%, 
respectively. Fish were fed to satiation and acclimatized in 
seawater for 9 days before the bath challenge. The shedder 
fish were bath anaesthetized with a mixture of metomidate 
(10 mg L−1) and benzocaine (60 mg L−1) before handling, 
and all fish were euthanized with a mixture of metomidate 
(10  mg L−1) and benzocaine (160  mg L−1) before tissue 
sampling.
Experimental design and bath challenge
The bath challenge model with SAV3 in seawater was car-
ried out as described previously [23], with some modifi-
cations. Briefly, 180 fish that served as shedder fish, were 
divided equally between three 150-L tanks containing 
seawater. Seven days prior to bath challenge, the shed-
der fish were intramuscularly injected with 103 TCID50 of 
SAV3 per fish. On the day of the bath challenge, the water 
flow to the three shedder tanks was stopped for 1 h, after 
which the shedder fish were removed and euthanized. 
The seawater containing SAV3 (SAV3-seawater) from all 
shedder tanks was mixed to prepare three doses of SAV3 
as follows: (i) undiluted SAV3-seawater (High dose) was 
transferred into Tanks 7 and 8; (ii) a 1:5 dilution of SAV3-
seawater (Medium dose) was transferred into Tanks 4, 
5 and 6; and (iii) a 1:75 dilution of SAV3-seawater (Low 
dose) was transferred into Tanks 1, 2 and 3. Then eighty-
one unvaccinated fish were randomly allocated into each 
of the 8 identical 150-L seawater tanks described above. 
Each tank contained 120 L of the respective SAV3 doses 
(Low, Medium or High), and the fish were bathed for 6 h. 
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The tanks were continually aerated, and the oxygen lev-
els were closely monitored during challenge. After 6 h the 
water flow was resumed. All tanks were monitored for an 
hour after the water flow was restarted to ensure welfare 
of the fish. This study was approved by the Norwegian 
Animal Research Authority (NARA) and carried out in 
strict accordance with the guidelines.
Salmonid alphavirus (SAV)
The SAV3 isolate used for infection of shedder fish in 
the present study originated from Atlantic salmon heart 
[28] and was kindly provided by Øystein Evensen, Nor-
wegian University of Life Sciences, Faculty of Veteri-
nary Medicine and Biosciences. SAV3 was propagated 
in Chum salmon heart-1 (CHH-1) cells cultured in L-15 
medium (Life Technologies, UK) supplemented with 2% 
FBS (PAA, France) and Penicillin–Streptomycin-Ampho-
tericin B (PSA) (Lonza, USA) at 15  °C. SAV3 was har-
vested 7 days after inoculation when a cytopathic effect 
(CPE) was observed. Quantification of virus stock was 
performed using end-point dilution assay on CHH-1 
cells, and TCID50 mL−1 was calculated [29].
Tissue sampling
Eight fish per tank were sampled at each sampling time-
point. Weight and length were recorded. Blood was col-
lected from the caudal vein into a microtube without 
anticoagulant at 7, 10, 14 and 21 dpe. Sera were collected by 
centrifugation (9500 g, 10 min) after storage of blood at 4 °C 
overnight. At 3, 7, 10, 14 and 21 dpe, hearts were dissected 
out of the fish and divided into 2 halves. One half was snap 
frozen in liquid nitrogen for RT-qPCR, while the other 
half was fixed in 10% neutral buffered formalin for histol-
ogy. At 14 dpe, pancreas tissue associated with the pyloric 
caeca was also sampled and fixed in the same way as the 
hearts. Tissue samples for histology were also taken from 
fish in the Low dose tanks at 21 dpe, since we expected that 
this dose would result in a low prevalence of SAV3-positive 
individuals and/or a delay in detection of histopathologi-
cal changes. A few samples were unfortunately lost during 
sample processing due to technical reasons.
Water sampling
Duplicate samples (2  ×  1  L) of seawater were collected 
from all three doses on the day of bath challenge. In addi-
tion, seawater was also collected from all 8 experimental 
tanks at 7, 10, 14, 17 and 22 dpe (1 × 1 L from each tank). 
Quantitation of the amount of SAV3 in the seawater sam-
ples was performed as described previously [22, 23] with 
some modifications. Briefly, water filtration based on the 
VIRADEL (virus-adsorption-elution) method was carried 
out using electropositive 1 MDS filters. One litre of sea-
water was collected, and concentrated by filtration. After 
filtration, the filters were placed upside down in petri-
dishes containing 1.2 mL of L-15 (Life Technologies, UK) 
supplemented with 10% FBS (PAA, France) and agitated 
at 500  rpm for 15  min on an orbital shaker. The eluant 
was collected and passed through a 0.22  µm syringe fil-
ter unit (Merck Millipore, Germany). One hundred µL of 
the eluant was then transferred into a microtube contain-
ing 350 µL of lysis buffer (iPrep™ PureLink™ Total RNA 
Kit, Invitrogen, USA.) and stored at −80 °C prior to qPCR 
analysis. The remaining eluant was used in an end-point 
dilution assay on CHH-1 cells. The presence of SAV3 
from eluant on the virus titration plate was confirmed by 
RT-qPCR [30] of the supernatant from cells showing CPE.
RNA extraction
Total RNA was extracted from heart tissue with TRIzol® 
reagent (Ambion) and an iPrep™ PureLink™ Total RNA 
Kit (Invitrogen, USA). Total RNA was quantified using 
a NanoDrop™-1000 spectrophotometer (Thermo Scien-
tific). RNA was extracted from 100 µL of serum samples 
and filtered water eluants using lysis buffer and an iPrep™ 
PureLink™ Total RNA Kit according to the manufactur-
er’s instructions. The extracted RNA was in a final vol-
ume of 50  µL. Known amount of Nodavirus was added 
into serum as an internal control.
In vitro synthesis of RNA standard
The viral RNA copy number was estimated using a 
SAV-specific RNA standard prepared as follows. SAV3 
RNA was extracted as described in the previous sec-
tion. A cDNA synthesis and PCR were performed to 
amplify a 576 bp fragment of the nsP1 gene using Ther-
moScript™ RT-PCR System and Platinum® Taq DNA 
polymerase (Invitrogen, USA.) according to the manu-
facturer’s recommendation. The following primers were 
used: forward primer with a T7 RNA polymerase pro-
moter (underlined): 5′ TAATACGACTCACTATAGG 
CTCACAGCTAACCCCTCCGCCGGCACTACAG 3′; 
and reverse primer: 5′ CGGCTCGAACCCGATCCAGT 
ATACCACTCGCGTGCC 3′. The PCR fragment was 
cleaned with a QIAquick PCR Purification Kit (Qiagen). 
The molecular weight of the cleaned product was veri-
fied on a 1% agarose gel (Seakem LE Agarose, Lonza), the 
concentration measured using a NanoDrop™-1000 spec-
trophotometer, and the sequence verified. Purified PCR 
products were in vitro transcribed using T7MEGAscript 
Kit (Ambion) at 37 °C for 16 h followed by DNase treat-
ment (TURBO DNA-free™ Kit, Ambion). Subsequently, 
the synthetic viral RNA (cRNA) was purified using RNe-
asy Mini Kit (Qiagen). The concentration of the puri-
fied cRNA was measured using a NanoDrop™-1000. 
The number of copies of the cRNA was calculated as 
described [31].
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cDNA synthesis and qPCR
The cDNA synthesis was performed using 200  ng total 
RNA from heart samples and 2 µL of cRNA (a ten-fold 
dilution series of cRNA to 101–1010 copies) and RNA 
from serum and water samples in a 10 µL reaction volume 
(SuperScript VILO cDNA Synthesis Kit). A 1:10 dilution 
of cDNA was then used in a qPCR assay targeting the 
SAV nsP1 gene for detection of SAV3 [30]. The sample 
and standard mixture was prepared using TaqMan® Fast 
Universal Master Mix (Applied Biosystems®) with 2 µL of 
diluted cDNA in a reaction mix containing 900 nM each 
of forward and reverse primers, and 250 nM of probe in a 
total volume of 10 µL on 384 well-plates. The qPCR assay 
was performed using ABI 7900HT Fast Real-Time PCR 
system (Applied Biosystems) and the temperature profile 
was adjusted as follows; activation at 95  °C for 20  s fol-
lowed by 40 cycles of denaturation at 95 °C for 10 s, and 
annealing and extension at 60 °C for 20 s. Standards were 
included in each qPCR run and a threshold value of 0.1 
applied to all samples. The standard curve and quantifica-
tion of SAV3 RNA copies in samples were constructed and 
calculated automatically with the SDS software version 
and heart after SAV3 infection from Medium and High 
dose using Statistica 12 (StatSoft, Inc., OK, USA). Data 
from the Low dose was not included as very few SAV3-
positive samples were detected.
Fulton’s condition factor (K-factor) was calculated 
using the following formula, K-factor = 100 × weight (g)/
[fork length (cm)]3, A t test was performed to analyze dif-
ferences between K-factors using Statistica 12.
The estimated virus shedding rate in each experimental 
tank was calculated from virus titre, as measured by the 
end-point dilution assay, using the formula given below. 
This estimation is presented in units of TCID50 h−1 kg−1. 
The virus titre in the sample was back-calculated to the 
concentration in each of the experimental tanks using a 
concentration factor. The calculation was based on the 
following assumptions: virus was being constantly shed 
by fish in the population; virus particles were equally dis-
tributed in the seawater; the flow rate was constant; and 
the virus recovery from seawater samples was close to 
100%. The virus titre in the sample was first calculated as 
described below. The flow rate and biomass in the tank 
were also taken into account in the final calculation.
Estimated shedding rate
(
TCID50h
−1kg−1
)
=
TCID50L
−1of seawater× concentration factor (L)×
flow rate
(
L h−1
)
volume of seawater in tank (L)
remaining biomass in tank
(
kg
) .
2.4.1 (Applied Biosystems, California, USA). The number 
of copies of SAV3 RNA in the sample was presented as per 
2 µL of total RNA from serum, per 200 ng of total RNA 
from heart or per 2  µL of total RNA from concentrated 
seawater. Approximately 15% of randomly picked serum 
samples, representing all treatment groups and sampling 
points, were checked for nodavirus [32], which was added 
as an internal control, to validate the quality of the RNA 
extraction and cDNA synthesis and all the samples tested 
showed a satisfactory level of nodavirus.
Histology
Pancreas and heart tissue from fish with SAV3-positive 
hearts, identified using qPCR, at 14 dpe (Low dose, 
n = 1; Medium dose, n = 5; High dose, n = 5) and at 21 
dpe (Low dose, n = 1) were processed and embedded in 
paraffin wax. Three µm tissue sections were prepared, 
stained with Haematoxylin-Erythrosin-Saffron (HES) and 
examined by light microscopy.
Data analysis
A Spearman’s rank-order correlation was used to deter-
mine the correlation between log10 viral loads in serum 
In this experiment, a concentration factor of 150 was 
used, and was calculated as a result of the volume of sea-
water in the experimental tank (150 000 mL) divided by 
the volume of the eluant recovered from the filter, which 
was approximately 1 mL (1000 times).
A Kruskal–Wallis test was used to compare prevalence 
of SAV3 nsP1-positive sera and hearts, also the log10 viral 
load in sera and in hearts between the three doses using 
Statistica 12.
Results
Bath challenge
Fish exposed to all three experimental doses of virus by 
bath challenge were successfully infected with SAV3. 
However, there was also a degree of variation between 
replicates depending on the viral dose. The SAV3 titre of 
the Low, Medium and High viral doses used for 6-h bath 
challenge, were 7, 27 and 139 TCID50 L−1 of seawater, 
respectively (Table 1). Some mortality was also observed 
in the Low (4 fish), Medium (4 fish) and High (1 fish) 
dose groups, but only three of these fish from Medium 
and High dose groups were subsequently shown to be 
SAV3-positive by qPCR.
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Fulton’s condition factor (K‑factor)
The condition factor in the present study was between 
0.90 and 1.46 and K-factors between the three doses at 
any sampling time were not statistically different. Over-
all, the K-factor decreased in all groups during the exper-
iment, and this decrease was detected as early as 7 dpe in 
all three doses. Significant differences in K-factors were 
observed in all three doses, between the beginning (0 
dpe) and the end of the experiment (22 dpe) (Figure 1).
Relationship between viral load in sera and in hearts
The viral load in sera and hearts was tested to see if a cor-
relation between these two parameters could be demon-
strated. As there were very few SAV3-positive fish in the 
Low dose group they were excluded from this test. Spear-
man’s correlation coefficients demonstrated a strong 
positive correlation during the early phase of infection in 
the Medium (10 and 14 dpe) and the High (7, 10 and 14 
dpe) dose groups (Table 2). A closer examination of the 
data at the level of individual fish showed that, generally, 
the increase in viral load was initially observed in serum 
and then in the heart. This was followed by a decrease in 
the viral load in serum and a slight increase or stabiliza-
tion of the viral load in the heart.
Outcome of SAV3 infection
In this section, an overview of the results will be 
described first, followed by a more detailed description of 
the results from each viral dose.
The present study aimed to generate data on the rela-
tionship between viral dose and the outcome of SAV3 
infection in Atlantic salmon post-smolts after a water-
borne exposure to SAV3, in addition to studying the 
progress and severity of the infection. Results from 10 
dpe showed that, as the viral dose was increased, the 
prevalence of viraemic fish, prevalence of SAV3-positive 
hearts, and viral shedding rate also increased (Table 1).
The prevalence of viraemic fish and SAV3-positive 
hearts were positively correlated with viral dose, espe-
cially between 7–14 dpe (Figure 2). Viral load in sera was 
high in the period of 10–14 dpe in Medium and High 
dose then decreasing trends were observed at 21 dpe for 
all three doses (Figure 3G). Viral load in hearts from all 
three doses showed that the viral load in the positive fish 
reached a comparable level towards the end of the exper-
iment, regardless of viral dose (Figure 3H).
Virus shedding could be detected using both RT-qPCR 
and end-point dilution assays. In addition, our data 
showed that end-point dilution assays detected virus in 
water samples more frequently than RT-qPCR (Addi-
tional file 1). Importantly, the end-point dilution method 
detects live virus in samples of epidemiological impor-
tance in the spread of the disease. The viral shedding data 
derived from the end-point dilution assays will be dis-
cussed in more detail below.
Table 1 Overview of dose–response from bath challenge 
of SAV3 in Atlantic salmon post-smolt
Prevalence of viraemic fish, prevalence of SAV3-positive heart and viral shedding 
rate in the tank-seawater at 10 dpe are shown for each infection dose.
Treatment SAV3 expo‑
sure dose 
(TCID50 L
−1 
of seawater)
Prevalence 
of viraemic 
fish (%)
Prevalence 
of SAV3‑
positive 
heart (%)
Viral shed‑
ding rate 
in tank‑
seawater 
(TCID50 h
−1 
kg−1)
Low 7 4 0 1364
Medium 27 21 25 7113
High 139 81 63 24 129
0 3 7 10 14 21 22
1.08
1.10
1.12
1.14
1.16
1.18
1.20
1.22
1.24
Low Medium High
*
**
K
-f
ac
to
r
Days post-exposure
Figure 1 Fulton’s condition factor (K-factor). Mean ± SEM from 
Atlantic salmon post-smolts bath challenged with Low (black circle), 
Medium (black square) and High (black triangle) doses of SAV3. Com-
parison of K-factor between the beginning (0 dpe) and the end of 
the experiment (22 dpe) within the same dose group was carried out 
by using the t test and significant difference was observed. *p < 0.05, 
**p < 0.01.
Table 2 Relationship between log10 viral loads in serum 
and heart from Medium and High dose
Spearman’s correlation coefficient (rs) and number of sample in brackets.
na: not applicable.
** p < 0.01.
Days post‑exposure (dpe) rs
Medium High
7 na (24) 0.818 (16)**
10 0.765 (24)** 0.922 (16)**
14 0.826 (24)** 0.709 (16)**
21 0.116 (17) 0.431 (16)
Page 6 of 13Jarungsriapisit et al. Vet Res  (2016) 47:102 
The severity of the histopathological lesions observed 
also appeared to correlate with SAV3 dose. The PD-
associated histopathological lesions in the heart were 
most prominent in individuals exposed to the High dose. 
Overall, a viral load of ≥105 SAV3 RNA copies per 200 ng 
of total RNA from heart corresponded to the observation 
of PD-related histopathological lesions in heart.
Low dose
Prevalence: The prevalence of viraemic fish and SAV3-
positive hearts varied among the replicate tanks (Fig-
ures 2A and B; Table 3). SAV3 was detected at 10, 14 and 
21 dpe in serum (Figure 2A) and at 7, 14 and 21 dpe in 
heart (Figure 2B). In addition, viraemic fish were detected 
only from Tank 1 at 10 and 14 dpe, while at 21 dpe fish in 
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Figure 2 Prevalence of infection following experimental bath challenge with SAV3 in post-smolts. Prevalence of viraemia in sera  
(A, C and E), and SAV3-positive hearts (B, D and F) from the Low (A and B), Medium (C and D) and High (E and F) doses. Bars (white, grey and black) 
represent triplicate or duplicate tanks from the Low (1, 2 and 3) and Medium (4, 5 and 6) and High (7 and 8) doses. No hearts were positive for SAV3 
at 3 dpe and are thus not shown. Numbers in brackets over columns in A, B and D indicate the number of samples analysed when it deviated from 
n = 8.
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Figure 3 Viral load measured by RT-qPCR following experimental bath challenge with SAV3 in post-smolt. The results represent viral 
load in sera (A, C and E) and hearts (B, D and F) from Low (A and B), Medium (C and D) and High (E and F) doses. In each graph results are pre-
sented either as Box and whisker plots (median, quartiles and range) when 4 or more individuals per group were positive; whiskers without boxes 
when only 2 or 3 individuals per group were positive; a dash when a single positive individual per group was positive. Copy numbers are per 100 µL 
of serum or per 200 ng of total heart RNA. Line graphs with dashed lines represent the average medians of the viral load in sera (G) and heart (H) 
over the experimental period from all three doses.
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all 3 replicate tanks were viraemic (Figure 2A). In addi-
tion, SAV3-positive hearts were detected only from Tank 
3, with a slight increase in prevalence over time (Fig-
ure 2B; Table 3).
Viral load: SAV3 was not detected in sera at 7 dpe (Fig-
ure  3A), but it was detected in hearts from the fish in 
Tank 3 (Figure 3B). Low amounts of SAV3 (6–1.1 × 103 
copies) were detected in sera from fish at 10 (Tank 1), 14 
(Tank 1) and 21 dpe (all replicate tanks) (Figures 3A and 
G). SAV3-positive hearts were detected at 7, 14 and 21 
dpe with a substantial difference in viral loads (20, 2 and 
2.3 × 105 copies, respectively) (Figures 3B and H; Addi-
tional file  2). The average virus shedding was low or 
below the detection limit throughout the experimental 
period (0–22 TCID50 L−1 of seawater) (Figure 4A), result-
ing in a low shedding rate (0–2.90  ×  103 TCID50 h−1 
kg−1) throughout the experimental period (22 days) with 
no shedding detected at 17 dpe (Table 4). 
Histopathology: SAV3-positive fish from the Low dose 
did not show any of the characteristic PD-associated his-
topathological lesions in the pancreas or the heart at 14 
dpe, PD-associated lesions were observed in the SAV3-
positive fish from this group at 21 dpe (Figures 5A and B).
Medium dose
Prevalence: The prevalence of viraemic fish and SAV3-
positive hearts varied among the three replicate tanks with 
less variation than for the Low dose group (Figures 2C and 
D). In general, fish in all three replicate tanks were SAV3-
positive at all time-points. However, at 7 dpe SAV3 was 
detected in sera from fish in 2 out of 3 tanks, but the hearts 
were not yet positive (Figures 2C and D). The average prev-
alence of SAV3-positive sera and hearts increased over 
time reaching 88 and 96%, respectively, at 21 dpe (Table 3).
Table 3 The percentage prevalence of SAV nsP1 in sera and hearts as an average of 3 or 2 tanks per group and 95% confi-
dence intervals (CI)
dpe: days post-exposure.
Dose dpe Sera Hearts
7 10 14 21 7 10 14 21
Low
 Mean 0 4.2 27.8 16.7 4.2 0 4.2 6.7
 95% CI 0–14.3 0.1–21.1 9.7–53.5 4.7–37.4 0.1–21.1 0–14.3 0.1–21.1 0.1–23.8
Medium
 Mean 16.7 20.8 66.7 87.5 0 25.0 54.2 95.8
 95% CI 4.7–37.4 7.1–42.2 44.7–84.4 67.6–97.3 0–14.3 9.8–46.7 32.8–74.5 76.2–100
High
 Mean 62.5 81.2 100 81.2 50.0 62.5 93.8 100
 95% CI 35.4–84.8 54.6–96.0 79.4–100 54.4–96.0 24.7–75.4 35.4–84.8 69.8–99.8 79.4–100
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Figure 4 Viral shedding of SAV3 from bath challenged post-
smolts. Each of the symbols (black circle, black square, black triangle) 
represent SAV3 titre (TCID50 L
−1 of seawater) from 1L of seawater (one 
biological replicate), in the Low (1, 2 and 3), Medium (4, 5 and 6), and 
High (7 and 8) dose tanks. The same scale for the y-axes is shown in 
each plot to facilitate direct comparison between doses.
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Viral load: SAV3 was detected in sera from fish in 
Tanks 5 and 6 at 7 dpe (Figure  3C) which coincided 
with detection of SAV3 in the tank-water (Figure  4B). 
However, SAV3 was not detected in hearts at 7 dpe (Fig-
ure  3D). SAV3 was detected in sera, hearts and water 
in all 3 replicate tanks from 10 dpe and onwards (Fig-
ures 3C, D; 4B). The viral load in sera increased between 
7–14 dpe (2.1 × 103, 1.2 × 104 and 2.6 × 105 copies at 7, 
10 and 14 dpe, respectively), and then declined at 21 dpe 
(1.5 × 103 copies) (Figure 3C; Additional file 2). The viral 
load in hearts increased throughout the experimental 
period (8.3 × 101, 3.4 × 103 and 7.9 × 104 copies at 10, 14 
and 21 dpe, respectively) (Figure 3D; Additional file 2). At 
7 dpe the level of SAV3 in the water was low (26 TCID50 
L−1 of seawater). The level of SAV3 was higher at 10 dpe 
(72 TCID50 L−1 of seawater) but then declined again at 14 
dpe (24 TCID50 L−1 of seawater) (Figure 4B). In addition, 
there was an increase in average virus shedding after 14 
dpe (95 and 121 TCID50 L−1 of seawater at 17 and 22 dpe, 
respectively) (Figure  4B, dashed line). In the Medium 
dose fish, the shedding rate was low but was higher than 
the shedding rate from the Low dose fish (Table 4).
Histopathology The PD-associated histopathological 
lesions in pancreas and heart tissue of SAV3-positive fish 
from the Medium dose group were observed at 14 dpe 
(Figures 5C and D). It is worth noting that a proportion 
of the samples showed more severe histopathological 
lesions in pancreas than in heart.
High dose
Prevalence The prevalence of viraemic fish and SAV3-
positive hearts was relatively similar between the 
two replicate tanks (Figures  2E  and F). In both repli-
cate tanks SAV3 was detected in sera and hearts at all 
sampling time-points (Figures  2E  and F). The average 
prevalence of SAV3-positive sera increased from 63% 
(7 dpe) to 81% (10 dpe), and peaked at 100% (14 dpe) 
before declined to 81% (21 dpe) (Table 3) while the aver-
age prevalence of SAV3-positive hearts increased over 
time (50, 63 and 94% at 7, 10 and 14 dpi, respectively) 
and reached 100% at 21 dpe (Table  3). The prevalence 
of viraemic fish and SAV3-positive hearts of High dose 
were significantly different from Low and Medium dose 
at 10 dpe (p < 0.05).
Viral load SAV3 was detected in sera, hearts and 
water in both replicate tanks from 7 dpe (Figures 3E, F; 
4C). The viral load in sera increased from 4.4 ×  103 (7 
dpe) to 4.9 × 105 copies (10 dpe), then declined slightly 
to 3.8 ×  105 (14 dpe) and to 1.0 ×  102 copies (21 dpe) 
(Figure  3E; Additional file  2), whereas the viral load in 
hearts increased over time (21, 7.4 × 103, 1.3 × 104 and 
1.2 × 105 copies at 7, 10, 14 and 21 dpi, respectively) (Fig-
ure 3F; Additional file 2). The log10 sera from High dose 
was significantly different from Low and Medium dose at 
7 and 10 dpe whereas it was significantly different from 
Low dose at 14 and 21 dpi (p < 0.05).
SAV3 was detected in water from the High dose group 
throughout the entire experimental period (Figure  4C). 
The pattern of virus shedding clearly showed only one 
peak at 10 dpe (243 TCID50 mL−1) in contrast to the 
shedding in the Medium dose tanks (Figures 4B and C). 
In the High dose, the shedding rate was comparable to 
the Medium dose at 7 dpe (2.66 × 103 TCID50 h−1 kg−1) 
but a substantial increase was seen at 10 dpe (2.41 × 104 
TCID50 h−1 kg−1). This was followed by a decrease at 14 
dpe (7.73 ×  103 TCID50 h−1 kg−1) and a low and stable 
rate of shedding was detected at 17 and 22 dpe (4.74 and 
6.21 × 103 TCID50 h−1 kg−1) (Table 4).
Histopathology SAV3-positive fish from the High dose 
group showed necrosis of exocrine pancreatic cells and 
degeneration of myocardial cells in the heart at 14 dpe 
(Figures  5E  and F). The SAV3-positive fish from this 
group also showed the most severe PD-related histo-
pathological lesions amongst the three doses.
Discussion
In the present work, we utilised a recently established 
bath challenge model [23] to study the relationship 
between viral dose and the outcome of SAV3 infection 
in Atlantic salmon post-smolts. Based on the detection 
of SAV3 in sera, hearts, and tank-water samples as well 
as observation of typical PD-related histopathological 
changes in the pancreas and heart, the bath challenge 
model has proven to be a valuable model to study the 
Table 4 Estimated SAV3 shedding rate into tank-seawater from experimentally bath challenged Atlantic salmon post-
smolts
Mean percentage prevalence of viraemic fish is given in brackets.
na: not applicable; dpe: days post-exposure.
Dose (dpe) Estimated shedding rate ± SEM (TCID50 h−1 kg−1 × 103)
7 10 14 17 22
Low 0.76 ± 0.11 (0%) 1.36 (4%) 1.61 ± 0.28 (28%) 0 (na) 2.90 ± 0.36 (17%)
Medium 2.16 ± 1.20 (17%) 7.11 ± 3.02 (21%) 2.74 ± 0.74 (67%) 13.39 ± 10.96 (na) 21.25 ± 16.08 (88%)
High 2.66 ± 0.05 (63%) 24.13 ± 13.44 (81%) 7.73 ± 5.27 (100%) 4.74 ± 1.81 (na) 6.21 ± 0.02 (81%)
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natural infection route of SAV3. The decrease in Fulton’s 
condition factor reported here has also been observed 
in other SAV3 infection studies [15, 23, 33]. Mortality in 
experimental SAV infection is difficult to reproduce [16, 
22, 23, 34], and only one cohabitation challenge study has 
demonstrated PD-related mortality (of approximately 
15%) [15]. In the present study, mortality undisputedly 
caused by SAV3 infection was not observed, however, 
SAV3 infection may have been a contributing factor to 
the observed mortality.
Figure 5 Histopathological changes in the pancreas and heart of Atlantic salmon post-smolts following SAV3 bath challenge. Necro-
sis of exocrine pancreatic cells (A, C and E) and degeneration of myocardial cells in the heart (B, D and F) in SAV3-positive fish from the Low dose 
(A and B) at 21 dpe, and from the Medium dose (C and D) and High dose (E and F) at 14 dpe. Solid arrowheads represent necrosis of pancreatic 
exocrine cells and open arrowheads represent myocardial degeneration. Scale bars represent 50 µm.
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The lowest concentration of SAV3 used in the 6 h-bath 
challenge (7 TCID50 L−1 of seawater) was able to cause 
infection in the challenged population as shown by 
detection of SAV3 in blood, heart, and in tank-water. 
Substantial variability between the replicate tanks was 
observed at this low SAV3 concentration, therefore, 7 
TCID50 L−1 of seawater is possibly close to the minimum 
dose required for waterborne SAV3 infection of post-
smolts of this size. In addition, from the three doses used 
in the bath challenge, we estimate the 50% infectious 
dose to be in the range of 27–139 TCID50 L−1 of seawater. 
This information may be useful in other dose–response 
studies.
In the present study, all the challenged fish were 
exposed to SAV3 at the same time, therefore, the infec-
tion was expected to develop homogeneously, espe-
cially during the early phase of disease progression. 
The failure to detect SAV3 in the hearts in the Low and 
Medium dose groups at early time-points might simply 
be explained by the SAV3 levels being below the level 
of detection of our assay. Alternatively, the prevalence 
of fish with SAV3-positive hearts could have been low. 
The detection of prevalence might be limited during the 
early phase of the experiment, which might explain the 
variability in detection especially in the low dose tanks. 
As the sampling continued, a higher percentage of the 
population sampled combined with the progress in dis-
ease development, may have increased the probability for 
prevalence detection. Therefore, improving the sensitiv-
ity of the detection method or increasing the number of 
samples analysed during surveillance programmes would 
likely improve the success of virus detection especially 
when the prevalence of SAV3-infected fish in the popula-
tion is low.
The prevalence of viraemia in sera, prevalence of SAV3-
positive hearts, and the virus shedding rates were used to 
determine the outcome of SAV3 infection. The degree of 
severity of the SAV3 infection in the challenged groups 
directly corresponded to the SAV3 dose in the bath chal-
lenge. Basically, a higher dose resulted in a higher per-
centage of infected fish in the population allowing the 
virus to spread throughout the entire population faster. 
In addition, the severity of PD-associated histopathologi-
cal lesions also showed a similar correlation to the SAV3 
exposure dose. The histopathological lesions in the heart 
were especially prominent in individuals with a SAV3 
RNA copy number above 105 per 200  ng of total RNA. 
This copy number value is similar to a previous study [28] 
(just above 106 viral RNA copies per 1 µg of total RNA) 
although the method was somewhat different. Interest-
ingly, a viral load above 105 copies per 200  ng of total 
RNA in the heart might be an indication of the presence 
of PD-related lesions in the hearts of fish with PD. It has 
been reported that the level of SAV1 in infected hearts 
could be as high as 106 copies at 11 days after intraperito-
neal injection [35].
Viral shedding rates of fish populations vary depend-
ing on the initial virus dose and the stage of the infection. 
In this present study, the maximal rate of viral shedding 
of 2.4 × 104 TCID50 h−1 kg−1 was observed in the High 
dose at 10 dpe. During PD outbreaks on fish farms, the 
biomass (kg) and the water current passing through a 
sea cage (L h−1) can be measured or estimated from 
the records. In addition, the prevalence of viraemic fish 
within a population and the virus shedding rate should 
also be possible to calculate. In the present study, the 
effect of viral dose on the prevalence of infected fish 
and the viral shedding rate at the population level was 
observed. When the prevalence of viraemic fish was 
taken into consideration for the calculation of virus shed-
ding rates, the maximal shedding rates from the Medium 
and High dose at 10 dpe were similar (3–4 × 104 TCID50 
h−1 kg−1). Hence, we speculate that maximal virus shed-
ding from individual fish is possibly constant or com-
parable in fish with similar characteristics (such as age, 
size, physiological condition, and genetic background). 
More research is clearly needed, but if our speculation is 
proved to be true, we may be able to better predict the 
virus shedding rate at the population level during natu-
ral outbreaks in real-time. A strong positive-correlation 
between viral loads in sera and hearts was observed in 
the High dose group during the first 14 dpe, indicating 
that higher viral loads in serum positively correlate with 
high viral loads in the heart early in the infection. A lower 
level of correlation at later time-points may indicate 
clearance of the virus from the bloodstream as specific 
antibody production can be observed 2–3  weeks after 
exposure to SAV [16, 34]. In contrast, the viral load in the 
hearts was relatively stable or slightly increased due to 
persistence of SAV in this organ [22, 23, 30]. At the end 
of the study, the Spearman correlation coefficient was 
markedly lower in the Medium dose group than in the 
High dose group. This suggests that clearance of the virus 
from the blood is more efficient when fish are exposed to 
a lower dose of virus. However, various stages of disease 
progression in this population may also contribute to the 
observed change in the correlation coefficient. This infor-
mation would be valuable if it could be used to describe 
the overall status of PD at a population level.
Contagious individuals likely shed virus through mucus 
and faeces [16, 36] and infect the remaining individuals 
within the same population resulting in multiple sequen-
tial infections within the population. In the present 
study, the increase in viral shedding at 10 and 22 dpe 
in the Medium dose group illustrates this scenario. The 
increase in the prevalence of viraemic fish (from 67 to 
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88%) and SAV-3 positive hearts (from 54 to 96%) at later 
time-points supports the scenario of multiple rounds of 
infection within the population. This is undoubtedly the 
scenario during SAV outbreaks at aquaculture sites [37]. 
Thus, the disease status of individuals or populations 
resulting from exposure to low levels of virus requires 
information from multiple samples such as blood, pan-
creas, heart, muscle and water and may employ various 
techniques such as RT-qPCR, end-point dilution assay, 
water filtration, serology and histology.
In the present study, a method allowing SAV3 to be 
isolated from seawater samples [22, 23] was combined 
with a conventional end-point dilution assay to quantify 
the amount of infectious virus. Although it is difficult 
to demonstrate the efficiency of virus recovery by this 
method, recovery of virus was in the same log concen-
tration in end-point dilution assay during optimization 
of the method (unpublished observations). Interestingly, 
quantification of virus using RT-qPCR was less sensitive 
than end-point dilution assay when SAV3 concentration 
in the water samples was low. Overall, water samples with 
viral titres below 100 TCID50 L−1 of seawater were not 
detected by RT-qPCR. However, the presence of SAV3 
in the supernatants from the end-point dilution assay 
could be confirmed using RT-qPCR. The small amounts 
of virus in the starting material and the probability of 
selecting a non-representative fraction during sample 
processing, such as extraction of nucleic acid and cDNA 
synthesis, prior to the RT-qPCR assay, might contribute 
to the loss of sensitivity. Similarly, virus multiplication in 
cell culture and replication of samples in the end-point 
dilution assay could contribute to the increased sensitiv-
ity of this method. Nevertheless, the high sensitivity of 
RT-qPCR methods for SAV detection in tissue samples 
are well-known [34, 38] and this was also true in the pre-
sent study as long as the virus concentration in samples 
was above the detection limit. In addition, RT-qPCR is 
a rapid detection method whereas the end-point dilu-
tion assay for SAV requires at least 3 days [39], but it also 
reflects the presence of infectious particles.
The method for quantification of infectious SAV3 in 
seawater samples reported here could be applied to field 
studies, although the presence of other viruses in the 
environment and the likely low amounts of SAV in sea-
water cages may complicate interpretation of the data 
and require further optimization of the method. Never-
theless, a preliminary attempt to apply this method for 
samples collected during a reported PD outbreak in the 
field confirmed that the method is applicable (unpub-
lished observation). It would be very interesting to add 
the viral shedding data and the SAV3 survival data into 
a pathogen dispersal model in order to improve the risk 
assessment of PD transmission during a natural outbreak. 
Improving the accuracy of both disease transmission and 
risk assessment models may lead to better control and 
mitigation of PD. This is of utmost importance for the 
sustainable growth of the fish farming-industry.
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